Fig. 1From: Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidenceTherapeutic sequence in HCC: different scenarios. Asterisks indicate that therapeutical sequences are possible but not yet documented in the literature. Use of regorafenib, ramucirumab and cabozantinib or lenvatinib after sorafenib has been proven to be effective. The role of Immune CPI alone or in combination with molecular targeted agents are still under investigationsBack to article page